Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million into Biohub, the nonprofit biomedical research organization founded by Mark Zuckerberg and his wife, Priscilla Chan, as reported by Reuters. The funding is part of a $1.8 billion initiative to build AI datasets that could allow researchers to “ask, predict, and answer biological questions digitally,” helping find new ways to prevent and manage diseases.

Founded in 2016, Biohub aims to combat diseases through the creation of a “virtual cell” that researchers can use to carry out simulations. To support this effort, the US Department of Ene …

Read the full story at The Verge.

This post was originally published on this site